C, W., & SE, S. (2020). Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. Frontiers in psychiatry, 11, 264. https://doi.org/10.3389/fpsyt.2020.00264
Chicago Style (17th ed.) CitationC, Westwell-Roper, and Stewart SE. "Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders." Frontiers in Psychiatry 11 (2020): 264. https://doi.org/10.3389/fpsyt.2020.00264.
MLA (9th ed.) CitationC, Westwell-Roper, and Stewart SE. "Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders." Frontiers in Psychiatry, vol. 11, 2020, p. 264, https://doi.org/10.3389/fpsyt.2020.00264.